Why is Hemo Organic falling/rising?

As of 14-Jul, Hemo Organic Ltd's stock price is currently at 9.99, reflecting an increase of 0.45 or 4.72%. Today's performance indicates that the stock has outperformed its sector by 4.95%, although it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. The stock has shown a 4.06% increase over the past week, contrasting with a significant decline of 9.18% over the past month. Despite positive quarterly results, including the highest PBDIT and PAT figures, the company faces challenges such as a negative book value, high debt levels, and a history of underperformance against benchmarks, which contribute to its overall weak long-term fundamental strength.
In the broader market context, Hemo Organic's recent short-term return of 4.06% over the past week stands in stark contrast to the Sensex, which has declined by 1.42% during the same period. However, the stock's year-to-date performance shows a significant decline of 19.82%, while the Sensex has gained 5.27%. This consistent underperformance against the benchmark over the last three years highlights the stock's volatility and risk, particularly given its negative EBITDA and high debt-to-equity ratio, which may deter long-term investors despite the recent uptick in price.